To date, literature on the physiology and regulation of FGF21 in humans indicates that this important regulatory protein acts as both a marker of metabolic disease and a hormone with anti‐inflammatory and protective effects against the development of metabolic disease. The gene discussed is FGF21; the disease is Other metabolic disease.